EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasmonic nanophotothermal therapy: Destruction of 500 mm 3 subcutaneous human basal cell carcinoma with gold nanoparticles and near infrared laser

Sabrina Pesnel iD, Antoine Bertolotti, Sébastien Duquenne, Hassan Zahouani, Laurent Mortier, Jean-Luc Perrot, Anne-Laure Morel

Skin Research and Technology · 2024

DOI: 10.1111/srt.13890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Sabrina Pesnel und 6 weiteren Autor:innen. Beteiligte Einrichtung: TORSKAL, Sainte-Clotilde, Réunion, France. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Gold, Skin Neoplasms, Metal Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regional council of Reunion Island, Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance Multilesional basal cell carcinoma (BCC) are spread on sun exposed skin areas, including arms, face and back. The first‐line treatment remains the surgical resection or Mohs surgery. Despite its high complexity, Mohs surgery is well practiced in USA and Germany and presents very good results both in esthetic and in carcinology point of view. Large lesions more than 2 cm remain challenging to remove by topical cream used in photodynamic therapy (PDT). If these larger lesions are not treated in less than 1 month, they could grow deeply in the skin, thus enhancing the risk of reoccurrence and the severity of the disease. Despite this model herein studied, that is non melanoma skin cancer is a good prognostic cancer, the therapy aims to be applied to more aggressive melanoma skin cancers.

Aim

Total regression of large cutaneous lesions less than 1 month with no reoccurrence. Approach Tumor induction on murine model bearing a 500 mm 3 subcutaneous lesion. Increasing dose of gold nanoparticles at fixed initial concentration C0 = 0.3 mg/mL, infused into the tumor then exposition of the region of interest to NIR medical laser to assess the therapy. One or two intratumoral administration(s) were compared to surgery and control, that is no treatment, laser alone or nanoparticles alone.

Results

Gold nanoparticles alone or the NIR laser alone did not induce the tumor regression. The combination of laser and nanoparticles called plasmonic nanophotothermal therapy induced apoptosis. Derma and hypoderm do not show any visible gold nanoparticles and demonstrated a good cicatrization process.

Conclusion

Plasmonic nanophotothermal therapy using two doses of gold nanoparticles was the only protocol that proved its efficacy on large lesions in 14 days, that is 500 mm 3 on a murine model bearing human basal cell carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaGoldSkin NeoplasmsMetal NanoparticlesPhotothermal TherapyAnimalsHumansMiceCell Line, TumorPhotochemotherapyFemaleCombined Modality Therapy

Stichwörter der Autor:innen

NIR Laserbasal cell carcinomagold nanoparticleshyperthermiaphototherapy

Substanzen

Gold

Autor:innen und Institutionen

  • TORSKAL, Sainte-Clotilde, Réunion, France.
  • CICEC-INSERM1410, Service de Maladies-Infectieuses et Dermatologie, CHU Réunion, Saint-Pierre Cedex, Réunion, France.
  • SELARL de pathologie, Saint-Pierre Cedex, Réunion, France.
  • Ecole Centrale de Lyon, LTDS - TMM, Ecully Cedex, France.
  • CHRU Lille, Service de Dermatologie, Hôpital Huriez, Lille, France.
  • CHU Saint Etienne, Service de dermatologie, Hôpital Nord, Lille, France.

ORCID-Profile: Sabrina Pesnel

Förderung

  • Regional council of Reunion Island
  • Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche
  • European Regional Development Fund

Zitieren

APA

Pesnel, S., Bertolotti, A., Duquenne, S., Zahouani, H., Mortier, L., Perrot, J. L., & Morel, A. L. (2024). Plasmonic nanophotothermal therapy: Destruction of 500 mm 3 subcutaneous human basal cell carcinoma with gold nanoparticles and near infrared laser. Skin Research and Technology. https://doi.org/10.1111/srt.13890

Vancouver

Pesnel S, Bertolotti A, Duquenne S, Zahouani H, Mortier L, Perrot JL, et al. Plasmonic nanophotothermal therapy: Destruction of 500 mm 3 subcutaneous human basal cell carcinoma with gold nanoparticles and near infrared laser. Skin Research and Technology. 2024. doi:10.1111/srt.13890

BibTeX
@article{Pesnel2024,
  author = {Pesnel, Sabrina and Bertolotti, Antoine and Duquenne, Sébastien and Zahouani, Hassan and Mortier, Laurent and Perrot, Jean-Luc and Morel, Anne-Laure},
  title = {Plasmonic nanophotothermal therapy: Destruction of 500 mm 3 subcutaneous human basal cell carcinoma with gold nanoparticles and near infrared laser},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13890}
}
Kostenlos starten →